Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Belanoff Joseph K
Relationship:   Chief Executive Officer
City:   Menlo Park
State:   CA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   348,811    

Indirect Shares

  2,483,107      
Direct Value   $10,105,055    

Indirect Value

  $71,935,610      
Total Shares   2,831,918      
Total Value   $82,040,664      


Corcept Therapeutics Inc
 $10,105,055 Corcept Therapeutics Inc
 $10,105,055
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Corcept Therapeutics Inc CORT Chief Executive Officer 2022-07-06 348,811 2022-07-07 2,483,107    Premium*  
* Premium Members only  

Records found :    117         Free Registration Required For Full Results.    Limit: 25

Download
  Page 5 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
CORT Corcept Therapeutics Inc Chief Executive Officer   •       •       •   2005-01-05 4 AS $6.00 $15,000 D/D (2,500) 2,381,695 -
CORT Corcept Therapeutics Inc Chief Executive Officer   •       •       •   2004-12-29 4 GD $0.00 $0 D/D 150 2,384,195 -
CORT Corcept Therapeutics Inc Chief Executive Officer   •       •       •   2004-12-07 4 AS $5.79 $57,934 D/D (10,000) 2,384,345 -
CORT Corcept Therapeutics Inc Chief Executive Officer   •       •       •   2004-11-04 4 AS $6.01 $13,222 D/D (2,200) 2,394,345 -
CORT Corcept Therapeutics Inc Chief Executive Officer   •       •       •   2004-11-03 4 AS $6.10 $3,660 D/D (600) 2,396,545 -
CORT Corcept Therapeutics Inc Chief Executive Officer   •       •       •   2004-11-02 4 AS $6.00 $28,200 D/D (4,700) 2,397,145 -
CORT Corcept Therapeutics Inc Chief Executive Officer   •       •       •   2004-11-01 4 AS $6.40 $16,000 D/D (2,500) 2,401,845 -
CORT Corcept Therapeutics Inc Chief Executive OfficerOfficer   •       •       •   2004-04-14 3 IO $0.00 $0 D/D 0 2,404,345 -
CORT Corcept Therapeutics Inc CHIEF EXECUTIVE OFFICER   •       •      –    2016-11-10 4 OE $1.50 $450,000 D/D 300,000 2,464,195 0 -
CORT Corcept Therapeutics Inc Chief Executive Officer   •       –      –    2022-07-07 4 AS $26.26 $1,446,945 I/I (55,111) 2,483,107 0 %
CORT Corcept Therapeutics Inc Chief Executive Officer   •       •      –    2020-02-26 4 D $13.54 $275,377 D/D (20,338) 2,499,214 0 -
CORT Corcept Therapeutics Inc Chief Executive Officer   •       •      –    2019-03-20 4 D $11.93 $5,100,409 D/D (427,528) 2,519,552 0 -
CORT Corcept Therapeutics Inc Chief Executive Officer   •       –      –    2022-07-06 4 AS $26.27 $7,352,008 I/I (279,908) 2,538,218 0 %
CORT Corcept Therapeutics Inc CHIEF EXECUTIVE OFFICER   •       •      –    2016-11-07 4 OE $1.50 $750,000 D/D 500,000 2,570,662 0 -
CORT Corcept Therapeutics Inc Chief Executive Officer   •       •      –    2021-01-22 4 D $28.06 $13,499,329 D/D (481,088) 2,818,126 0 -
CORT Corcept Therapeutics Inc Chief Executive Officer   •       •      –    2019-03-20 4 OE $1.19 $931,633 D/D 782,885 2,947,080 0 -
CORT Corcept Therapeutics Inc Chief Executive Officer   •       •      –    2021-01-22 4 OE $4.42 $3,536,000 D/D 800,000 3,299,214 0 -

  117  Records found
  1   2   3   4   5     
  Page 5 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed